Skip to main content
Top
Literature
1.
go back to reference Sullivan R, Peppercorn J, Sikora K, Meropol N, Amir E, et al. Delivering affordable cancer care in high-income countries. Lancet Oncol. 2011;12:933–80.PubMedCrossRef Sullivan R, Peppercorn J, Sikora K, Meropol N, Amir E, et al. Delivering affordable cancer care in high-income countries. Lancet Oncol. 2011;12:933–80.PubMedCrossRef
2.
go back to reference Bockisch A. Matched pairs for radionuclide-based imaging and therapy. Eur J Nucl Med Mol Imaging. 2011;38 Suppl 1:S1–3.PubMedCrossRef Bockisch A. Matched pairs for radionuclide-based imaging and therapy. Eur J Nucl Med Mol Imaging. 2011;38 Suppl 1:S1–3.PubMedCrossRef
3.
go back to reference Giovacchini G, Picchio M, Coradeschi E, et al. Predictive factors of [11C]choline PET/CT in patients with biochemical failure after radical prostatectomy. EJNMMI. 2010;37:301–9. Giovacchini G, Picchio M, Coradeschi E, et al. Predictive factors of [11C]choline PET/CT in patients with biochemical failure after radical prostatectomy. EJNMMI. 2010;37:301–9.
4.
go back to reference Tolmachev V, Velikyan I, Sandstrom M, et al. A HER2-binding Affibody molecule labelled with Ga-68 for PET imaging: direct in vivo comparison with the In-111-labelled analogue. EJNMMI. 2010;37:1356–67. Tolmachev V, Velikyan I, Sandstrom M, et al. A HER2-binding Affibody molecule labelled with Ga-68 for PET imaging: direct in vivo comparison with the In-111-labelled analogue. EJNMMI. 2010;37:1356–67.
5.
go back to reference Dijkgraaf I, Kruijtzer JAW, Liu S, et al. Improved targeting of the alpha(v)beta(3) integrin by multimerisation of RGD peptides. EJNMMI. 2007;34:267–73. Dijkgraaf I, Kruijtzer JAW, Liu S, et al. Improved targeting of the alpha(v)beta(3) integrin by multimerisation of RGD peptides. EJNMMI. 2007;34:267–73.
6.
go back to reference Cai WB, Chen K, He LN, et al. Quantitative PET of EGFR expression in xenograft-bearing mice using Cu-64-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody. EJNMMI. 2007;34:850–8. Cai WB, Chen K, He LN, et al. Quantitative PET of EGFR expression in xenograft-bearing mice using Cu-64-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody. EJNMMI. 2007;34:850–8.
Metadata
Title
Nuclear medicine, scientific publishing and the era of cost containment
Author
Ignasi Carrió
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 12/2011
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-011-1982-y

Other articles of this Issue 12/2011

European Journal of Nuclear Medicine and Molecular Imaging 12/2011 Go to the issue